<DOC>
	<DOCNO>NCT00820560</DOCNO>
	<brief_summary>To establish maximum tolerate dose ( MTD ) INCB007839 give multiple dos 28 day determine high MTD establish INCB007839 administer combination prophylactic anticoagulation 2 half day ( 5 dos ) treatment interruption every two week .</brief_summary>
	<brief_title>Open-Label Study Assess Safety/Tolerability Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Either nonsmall cell lung cancer , hormonerefractory prostate cancer , colorectal cancer , breast cancer , squamous cell cancer head neck refractory standard treatment effective treatment exists . The patient must life expectancy 12 week longer . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Received anticancer medication 28 day prior receive first dose study medication Evidence venous thrombosis flow Doppler examination Screening A history thrombosis coagulation disorder Patients contraindication use low dose warfarin and/or aspirin . Any unresolved toxicity great grade 2 previous anticancer therapy , except stable chronic toxicity expect resolve Brain metastasis spinal cord compression Impaired renal function Inadequate bone marrow reserve</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>